Clinical Trials Directory

Trials / Sponsors / Cytos Biotechnology AG

Cytos Biotechnology AG

Industry · 18 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnCYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticost
Asthma
Phase 22014-05-01
TerminatedCYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma
Moderate to Severe Allergic Asthma
Phase 22012-11-01
CompletedSafety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 12009-06-01
CompletedCYT003-QbG10 for Treatment of Allergic Asthma Bronchial
Allergic Bronchial Asthma
Phase 22009-04-01
CompletedDose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy
Rhinoconjunctivitis, Allergies
Phase 22008-11-01
CompletedSafety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension
Mild Essential Hypertension, Moderate Essential Hypertension
Phase 22008-06-01
CompletedSafety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Pati
Malignant Melanoma
Phase 22008-04-01
CompletedStudy to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Again
Hypertension
Phase 22008-03-01
CompletedStudy to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
Perennial Allergy to House Dust Mite and/or Cat
Phase 22007-12-01
CompletedA Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivit
Perennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy
Phase 22007-11-01
CompletedA Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivit
Perennial Allergic Rhinoconjunctivitis, House Dust Mite Allergy
Phase 22006-09-01
CompletedSafety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
Hypersensitivity
Phase 1 / Phase 22006-02-01
CompletedEffect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite
Perennial Allergic Rhinoconjunctivitis, Allergic Asthma
Phase 1 / Phase 22005-03-01
CompletedSafety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension V
Essential Hypertension
Phase 1 / Phase 22004-11-01
CompletedEfficacy and Safety of Nicotine-Qbeta Vaccine in Smokers
Smokers
Phase 22003-12-01
CompletedSafety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
Malignant Melanoma
Phase 2
CompletedSafety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
Malignant Melanoma
Phase 1 / Phase 2
CompletedSafety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients
Melanoma
Phase 1 / Phase 2